Literature DB >> 30267878

Chondrogenic differentiation of synovial fluid mesenchymal stem cells on human meniscus-derived decellularized matrix requires exogenous growth factors.

Yan Liang1, Enaam Idrees2, Alexander R A Szojka2, Stephen H J Andrews2, Melanie Kunze2, Aillette Mulet-Sierra2, Nadr M Jomha2, Adetola B Adesida3.   

Abstract

The objective of this study was to investigate whether meniscus-derived decellularized matrix (DCM) has the capacity to induce differentiation of synovial fluid-derived mesenchymal stem cells (SF-MSCs) towards a meniscus fibrochondrocyte (MFC) phenotype. The potential roles of transforming growth factor beta-3 (TGF-β3) and insulin-like growth factor 1 (IGF-1) in the differentiation of SF-MSCs towards an MFC phenotype were also investigated. SF-MSCs were isolated via plastic adherence cell culture from the synovial fluid of five donors (5 male, average age 34 years). Porous DCM was generated by homogenizing and freeze-drying fresh normal human cadaveric meniscus tissue. SF-MSCs were seeded and cultured on the DCM scaffold in a defined serum-free media (SFM) supplemented with or without the combination of TGF-β3 and IGF-1. Cell pellets of SF-MSCs were cultured in SFM with either TGF-β3 or IGF-1 or their combination as controls. The duration of culture was 3 weeks for both experimental configurations. We assessed newly-formed tissues by biochemical assays, scanning electron microscopy (SEM), immunofluorescence and quantitative real-time PCR (qPCR). The combination of TGF-β3 and IGF-1 induced production of the cartilaginous matrix in DCM and upregulated the expression of aggrecan, collagens I and II. Moreover, the SF-MSCs exhibited a round morphology in the DCM scaffolds in the presence of the growth factors. In pellets, combined TGF-β3 and IGF-1 synergistically enhanced cartilaginous matrix production. In contrast to bone marrow mesenchymal stem cells (BM-MSCs), the differentiated SF-MSCs showed little evidence of the expression of the hypertrophic differentiation marker, collagen X. In conclusion, meniscus-derived DCM appears to require exogenous growth factor supplementation to direct differentiation of SF-MSCs. STATEMENT OF SIGNIFICANCE: Meniscus tears are the most common injury of the knee joint. These tears pose a major risk factor for the early development of knee osteoarthritis. Unfortunately, the majority of these tears occur in the inner region of the meniscus and lacks blood supply with no reparative or regenerative capacity. The goal of this study was to determine if the native extracellular matrix (ECM) of human meniscus has the capacity to differentiate human knee synovial fluid resident mesenchymal stem cells (SF-MSCs) towards a meniscus phenotype as a potential strategy to repair avascular meniscal tears. Our findings show that the human meniscus-derived ECM without supplementation with growth factors (TGF-β3 and IGF-1) cannot differentiate SF-MSCs towards a meniscus phenotype. The use of meniscus-derived scaffolds as a material to stimulate endogenous repair of meniscus tears via differentiation of SF-MSCs may require supplementation with TGF-β3 and IGF-1.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decellularized matrix; Meniscus; Stem cells; Synovial fluid; Tissue engineering

Mesh:

Substances:

Year:  2018        PMID: 30267878     DOI: 10.1016/j.actbio.2018.09.038

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  17 in total

Review 1.  Sources, Characteristics, and Therapeutic Applications of Mesenchymal Cells in Tissue Engineering.

Authors:  Rosa Angelica Gonzalez-Vilchis; Angelica Piedra-Ramirez; Carlos Cesar Patiño-Morales; Concepcion Sanchez-Gomez; Nohra E Beltran-Vargas
Journal:  Tissue Eng Regen Med       Date:  2022-01-29       Impact factor: 4.169

2.  Erythropoietin enhances meniscal regeneration and prevents osteoarthritis formation in mice.

Authors:  Xiao-Ning Fu; Hui-Wu Li; Na Du; Xu Liang; Shi-Hao He; Kuang-Jin Guo; Tian-Fang Li
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Evaluation of culture conditions for in vitro meniscus repair model systems using bone marrow-derived mesenchymal stem cells.

Authors:  Sofia Hidalgo Perea; Lucas P Lyons; James F Nishimuta; J Brice Weinberg; Amy L McNulty
Journal:  Connect Tissue Res       Date:  2019-10-29       Impact factor: 3.417

4.  Respective stemness and chondrogenic potential of mesenchymal stem cells isolated from human bone marrow, synovial membrane, and synovial fluid.

Authors:  Paul Neybecker; Christel Henrionnet; Elise Pape; Laurent Grossin; Didier Mainard; Laurent Galois; Damien Loeuille; Pierre Gillet; Astrid Pinzano
Journal:  Stem Cell Res Ther       Date:  2020-07-25       Impact factor: 6.832

Review 5.  Mesenchymal Stem Cells for Regenerative Medicine.

Authors:  Yu Han; Xuezhou Li; Yanbo Zhang; Yuping Han; Fei Chang; Jianxun Ding
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

6.  Meniscus-Derived Matrix Scaffolds Promote the Integrative Repair of Meniscal Defects.

Authors:  Jacob C Ruprecht; Taylor D Waanders; Christopher R Rowland; James F Nishimuta; Katherine A Glass; Jennifer Stencel; Louis E DeFrate; Farshid Guilak; J Brice Weinberg; Amy L McNulty
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

7.  Expression profiles of long non-coding RNAs in the cartilage of patients with knee osteoarthritis and normal individuals.

Authors:  Yanchang Liu; Juehua Jing; Haoran Yu; Jisen Zhang; Qiliang Cao; Xin Zhang; Jianjun Liu; Shuo Zhang; Wendan Cheng
Journal:  Exp Ther Med       Date:  2021-02-18       Impact factor: 2.447

Review 8.  Narrative review of the choices of stem cell sources and hydrogels for cartilage tissue engineering.

Authors:  Zhantao Deng; Jiewen Jin; Shuai Wang; Fangjie Qi; Xuepan Chen; Chang Liu; Yanbing Li; Yuanchen Ma; Fengjuan Lyu; Qiujian Zheng
Journal:  Ann Transl Med       Date:  2020-12

9.  Vitrification of particulated articular cartilage via calculated protocols.

Authors:  Kezhou Wu; Nadia Shardt; Leila Laouar; Janet A W Elliott; Nadr M Jomha
Journal:  NPJ Regen Med       Date:  2021-03-19

Review 10.  An Update on Mesenchymal Stem Cell-Centered Therapies in Temporomandibular Joint Osteoarthritis.

Authors:  Yifan Zhao; Liang Xie
Journal:  Stem Cells Int       Date:  2021-04-01       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.